ZA979338B - Peptide compounds. - Google Patents

Peptide compounds.

Info

Publication number
ZA979338B
ZA979338B ZA9709338A ZA979338A ZA979338B ZA 979338 B ZA979338 B ZA 979338B ZA 9709338 A ZA9709338 A ZA 9709338A ZA 979338 A ZA979338 A ZA 979338A ZA 979338 B ZA979338 B ZA 979338B
Authority
ZA
South Africa
Prior art keywords
peptide derivatives
novel peptide
peptide compounds
compounds
dependent
Prior art date
Application number
ZA9709338A
Other languages
English (en)
Inventor
Richard William Arthur Luke
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ZA979338B publication Critical patent/ZA979338B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/81Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
ZA9709338A 1996-10-19 1997-10-17 Peptide compounds. ZA979338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9621836.7A GB9621836D0 (en) 1996-10-19 1996-10-19 Peptide compounds

Publications (1)

Publication Number Publication Date
ZA979338B true ZA979338B (en) 1998-04-20

Family

ID=10801703

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709338A ZA979338B (en) 1996-10-19 1997-10-17 Peptide compounds.

Country Status (10)

Country Link
US (1) US6207644B1 (US06207644-20010327-C00004.png)
EP (1) EP0932618B1 (US06207644-20010327-C00004.png)
JP (1) JP2001508036A (US06207644-20010327-C00004.png)
AT (1) ATE256145T1 (US06207644-20010327-C00004.png)
AU (1) AU4633097A (US06207644-20010327-C00004.png)
DE (1) DE69726743T2 (US06207644-20010327-C00004.png)
GB (1) GB9621836D0 (US06207644-20010327-C00004.png)
TW (1) TW492868B (US06207644-20010327-C00004.png)
WO (1) WO1998017680A1 (US06207644-20010327-C00004.png)
ZA (1) ZA979338B (US06207644-20010327-C00004.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046578A1 (en) 1996-06-07 1997-12-11 Zeneca Limited Peptide derivatives
EP1198271A4 (en) 1999-06-25 2009-01-21 Univ Emory DEVICES AND METHODS FOR STIMULATING THE VAGUSNERVS
TW200502221A (en) 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
US7439231B2 (en) * 2003-02-14 2008-10-21 Provid Pharmaceuticals, Inc. Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof
JP2006520396A (ja) * 2003-03-14 2006-09-07 アストラゼネカ・アクチエボラーグ 新規なラクタム及びその使用
TWI356821B (en) * 2003-12-01 2012-01-21 Cambridge Entpr Ltd Anti-inflammatory agents
WO2009073168A1 (en) * 2007-12-03 2009-06-11 Provid Pharmaceuticals, Inc. Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474778A (en) 1983-11-09 1984-10-02 E. R. Squibb & Sons, Inc. Lactam containing compounds, their pharmaceutical compositions and method of use
DE3711335A1 (de) 1987-04-03 1988-10-20 Merck Patent Gmbh Aminosaeurederivate
US5223485A (en) 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
WO1992002543A1 (en) * 1990-08-01 1992-02-20 Cytel Corporation Novel immunosuppressant peptides
DE4034829A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh Cyclopeptide
AU2468392A (en) 1991-08-29 1993-04-05 Cytel Corporation Novel immunosuppressants
DK0644197T3 (da) 1993-06-04 1999-06-07 Vertex Pharma Peptidphosphinyloxymethylketoner som inhibitorer af interleukin-1beta-konverterende enzymer
AU698962B2 (en) 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
AU2238395A (en) 1994-04-01 1995-10-23 Immulogic Pharmaceutical Corporation Haptenated peptides and uses thereof
JPH10508035A (ja) 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物およびプロテアーゼインヒビターとしてのその使用
WO1997016425A1 (en) 1995-10-30 1997-05-09 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
US5817757A (en) * 1995-10-30 1998-10-06 Merck & Co., Inc. Inhibitors of peptide binding to MHO class II proteins
US5719296A (en) 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
US5840835A (en) * 1995-10-30 1998-11-24 Merck & Co., Inc. Inhibitors of peptide binding to MHC class II proteins
GB9702377D0 (en) 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
EP0932618A1 (en) 1999-08-04
DE69726743T2 (de) 2004-10-14
US6207644B1 (en) 2001-03-27
TW492868B (en) 2002-07-01
WO1998017680A1 (en) 1998-04-30
GB9621836D0 (en) 1996-12-11
EP0932618B1 (en) 2003-12-10
AU4633097A (en) 1998-05-15
DE69726743D1 (de) 2004-01-22
ATE256145T1 (de) 2003-12-15
JP2001508036A (ja) 2001-06-19

Similar Documents

Publication Publication Date Title
GB9716656D0 (en) Chemical compounds
LU91145I9 (US06207644-20010327-C00004.png)
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
TR199802537T2 (xx) Peptit t�revleri.
NZ330944A (en) Peptide derivatives
BG103417A (en) Condensed pyrimidine bicyclic derivatives
HK1051691A1 (en) Hydroxylstilbenes and stilbene derivatives and analogues of anti-inflammatory and psoriasis treatment and protein kinase inhibition
ATE229498T1 (de) Zelle adhäsion hemmenden verbindungen
MY124122A (en) Heterocyclic derivatives
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
ZA943744B (en) Therapeutic substituted guanidines
UA48946C2 (uk) Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
IL99912A0 (en) Cyclosporins,their preparation and pharmaceutical compositions containing them
SE9702001D0 (sv) Novel compounds
HK1048990A1 (en) Novel compounds.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
AU6469401A (en) Pharmaceutically active compounds and methods of use
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
ZA979338B (en) Peptide compounds.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer